RFG
BMY icon

REAP Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

REAP Financial Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.7K Buy
985
+106
+12% +$6.18K 0.01% 268
2025
Q4 		$47.4K Buy
879
+182
+26% +$8.76K 0.01% 306
2025
Q3 		$31.4K Buy
697
+58
+9% +$2.71K 0.01% 315
2025
Q2 		$29.6K Buy
639
+428
+203% +$21K 0.01% 319
2025
Q1 		$12.9K Buy
211
+54
+34% +$3.15K ﹤0.01% 347
2024
Q4 		$8.88K Buy
157
+146
+1,327% +$8.16K ﹤0.01% 379
2024
Q3 		$579 Hold
11
– – ﹤0.01% 559
2024
Q2 		$459 Sell
11
-141
-93% -$6.31K ﹤0.01% 516
2024
Q1 		$8.24K Buy
152
+141
+1,282% +$7.18K ﹤0.01% 393
2023
Q4 		$553 Buy
+11
New +$577 ﹤0.01% 620

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

REAP Financial Group's BMY Position: Q1 2026 in Review

REAP Financial Group increased its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2026, buying an estimated $6.18K and bringing the position to 985 shares worth $59.7K. The position accounts for 0.01% of the portfolio, ranked #268.

REAP Financial Group first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • REAP Financial Group held 985 shares of Bristol-Myers Squibb worth $59.7K as of Q1 2026.
  • REAP Financial Group bought 106 Bristol-Myers Squibb shares in Q1 2026, an estimated $6.18K.
  • Bristol-Myers Squibb made up 0.01% of REAP Financial Group's portfolio in Q1 2026, its #268 holding.
  • REAP Financial Group first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on REAP Financial Group's 13F filing for Q1 2026, filed 11 May 2026.